supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“… alanine … vitamin E and with pioglitazone, as compared with placebo (P<0.001 for both comparisons), and both agents were associated with reductions in hepatic steatosis (…=0.004 for pioglitazone) but not with improvement in fibrosis scores (P=0.24 for vitamin E and P=0.12 for pioglitazone).”
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.“On the other hand, only one of the four RCTs conducted on children showed significant improvements in liver … quantitative synthesis of available data revealed insignificant differences between vitamin E and placebo, still the use of vitamin E … alanine transaminase and aspartate transaminase by −1.…=67% and I2=0%, respectively.”
“They also conclude that serum alanine and aspartate aminotransferase levels were reduced with vitamin E treatment.”
“Quercetin and vitamin E significantly reduced the blood glucose level, degree of tissue peroxidation and alanine and aspartate amino transferase activity.”
Inhibition of liver mitochondrial membrane permeability transition pore opening by quercetin and vitamin E in streptozotocin-induced diabetic rats.“ Vitamin E was ineffective at improving alanine transaminase levels, while omega-3 fatty acids decreased hepatic fat content.”
Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Non-alcoholic Fatty Liver Disease.“… alanine … vitamin E and with pioglitazone, as compared with placebo (p <0.001 for both comparisons), and both agents were associated with reductions in hepatic steatosis (… = 0.004 for pioglitazone) but not with improvement in fibrosis scores (p = 0.24 for vitamin E and p = 0.72 for pioglitazone).”
“… alanine … vitamin E and with pioglitazone, as compared with placebo (P<0.001 for both comparisons), and both agents were associated with reductions in hepatic steatosis (…=0.004 for pioglitazone) but not with improvement in fibrosis scores (P=0.24 for vitamin E and P=0.12 for pioglitazone).”
“… alanine … vitamin E and with pioglitazone, as compared with placebo (P<0.001 for both comparisons), and both agents were associated with reductions in hepatic steatosis (…=0.004 for pioglitazone) but not with improvement in fibrosis scores (P=0.24 for vitamin E and P=0.12 for pioglitazone).”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback